Cellectis (CLLS) Tops Q1 EPS by 7c

Cellectis (NASDAQ: CLLS) reported Q1 EPS of ($0.17), $0.07 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $12 million versus the consensus estimate of $11.96 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• DEFSEC Technologies (DFSC) files for 4.05M share offering by selling stockholders
• DoJ requests beef price data from major retailers including Amazon and Walmart